EP Patent

EP0796271B1 — Dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten

Assigned to Abbott GmbH and Co KG · Expires 2000-02-02 · 26y expired

What this patent protects

Patent listed against delafloxacin-meglumine.

Drugs covered by this patent

delafloxacin-meglumine (DELAFLOXACIN MEGLUMINE)

Patent Metadata

Patent number: EP0796271B1
Jurisdiction: EP
Classification: —
Expires: 2000-02-02
Drug substance claim: No
Drug product claim: No
Assignee: Abbott GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.